19th Sep 2008 12:07
Sinclair Pharma: Date of Preliminary Results
19 September, Godalming, UK. Sinclair Pharma plc (SPH.L), the international specialty pharma company, will announce its preliminary results for the year ended 30 June 2008 on Wednesday 1 October 2008.
-Ends-
For further information please contact:
Sinclair Pharma plc Tel: +44 (0)1483 410 600
Dr Michael Flynn, CEO
Jerry Randall, CFO
Mariyam Rawat, Communications & Investor Relations [email protected]
Capital MS&L Tel +44 (0)20 7307 5330
Mary Clark
Anna Mitchell
Notes to editors:
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, UK, Spain and Portugal, and a complementary marketing partner network that spans more than 80 countries.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
Related Shares:
Sinclair Pharma